Dr. Cynthia Santiago, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5 Roosevelt Ave, Port Jefferson Station, NY 11776 Phone: 631-732-6984 Fax: 631-732-7019 |
Dr. Mark A Shapiro, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 10 B Medical Dr, Port Jefferson Station, NY 11776 Phone: 631-474-1111 Fax: 631-474-4694 |
Dr. Aziz Chaudry, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2b Medical Park Drive, Port Jefferson Station, NY 11776 Phone: 631-928-1414 Fax: 631-928-1830 |
Dr. Antoun Saba Mitromaras, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 509 Route 112, Port Jefferson Station, NY 11776 Phone: 631-331-1100 |
Gino A Consigliere, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 7 Medical Dr Ste A, Port Jefferson Station, NY 11776 Phone: 631-928-5252 Fax: 631-928-5259 |
News Archive
A group of "major health agencies" from Australia, Canada, China, the U.K. and the U.S., which "together control 80 percent of the world's public health-research funding," have joined together to form the Global Alliance for Chronic Diseases (GACD) to combat chronic diseases in developing countries, Time reports (Walsh, Time, 6/16).
Experts at The University of Texas MD Anderson Cancer Center advise men to keep a record of their prostate specific antigen (PSA) test results to help determine if they are at increased risk for prostate cancer.
Mallinckrodt plc, a leading global specialty biopharmaceutical company, and Ikaria, Inc. a privately-held critical care company, announced today that they have entered into a definitive agreement under which a subsidiary of Mallinckrodt will acquire Ikaria, Inc. from a Madison Dearborn-led investor group in a transaction valued at approximately $2.3 billion.
Identifying and resolving barriers to the successful implementation of evidence-based practice (EBP) helped a hospital make EBP an integrated part of its organizational culture, according to an article in the June issue of Critical Care Nurse (CCN).
Two years ago, mammalian target of rapamycin or mTOR, a signaling protein, was identified as a key mediator of the antidepressant effects of ketamine, the first rapidly acting antidepressant medication to be identified.
› Verified 1 days ago